Serif Contrasted Peze 3 is a bold, normal width, high contrast, upright, normal x-height font.
Keywords: headlines, editorial, book covers, posters, branding, traditional, authoritative, formal, literary, classic revival, display impact, print authority, editorial tone, bracketed, beaked, ink-trap feel, ball terminals, vertical stress.
A sturdy serif with pronounced vertical stress and crisp transitions from thick stems to finer connecting strokes. Serifs are firm and mostly bracketed, with several glyphs showing beaked or wedge-like ends that give the face a slightly inscribed, print-centric texture. Curves are compact and tightly controlled, counters are relatively closed, and the overall rhythm is dense without feeling condensed. Lowercase forms are conventional and readable, with a two-storey “a,” a compact “e,” and a single-storey “g,” while figures are heavy and blocky with strong top and bottom emphasis.
Best suited to headlines, editorial titling, and book or magazine covers where its strong serif structure and dense color can carry a page. It can also work for branding and packaging that wants a traditional, authoritative voice, especially when set with generous tracking and comfortable line spacing.
The tone is sober and editorial, leaning toward classic print authority rather than sleek modern minimalism. Its sharp serif presence and high-contrast detailing convey seriousness and tradition, while the slightly chunky weight keeps it grounded and emphatic in display settings.
Likely designed to evoke classic serif typography with a punchier, darker color for contemporary editorial impact. The emphasis on vertical stress, assertive serifs, and compact counters suggests an intention to balance tradition with strong display presence.
At text sizes the face reads dark and steady, with prominent horizontal features (serifs and crossbars) creating a strong baseline and cap-line. Several joins and inner corners appear tightened, producing a subtle engraved/ink-trap impression that can add character in print-like treatments.